{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:44:47Z","timestamp":1794663887459,"version":"4.9.1"},"reference-count":108,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Follicular lymphoma (FL) is a neoplasm derived from germinal center B cells, composed of centrocytes and centroblasts, with at least a focal follicular growth pattern. The t(14;18) translocation together with epigenetic deregulation through recurrent genetic alterations are now recognized as the hallmark of FL. Nevertheless, FL is a heterogeneous disease, clinically, morphologically, and biologically. The existence of FL lacking the t(14;18) chromosomal alteration highlights the complex pathogenesis of FL, and indicates that there are alternative pathogenetic mechanisms that can induce a neoplasm with follicular center B-cell phenotype. Based on their clinical presentation, t(14;18)-negative FLs can be divided into 3 broad groups: nodal presentation, extranodal presentation, and those affecting predominantly children and young adults. Recent studies have shed some light into the genetic alterations of t(14;18)-negative FL. Within the group of t(14;18)-negative FL with nodal presentation, cases with STAT6 mutations are increasingly recognized as a distinctive molecular subgroup, often cooccurring with CREBBP and\/or TNFRSF14 mutations. FL with BCL6 rearrangement shows clinicopathological similarities to its t(14;18)-positive counterpart. In contrast, t(14;18)-negative FL in extranodal sites is characterized mainly by TNFRSF14 mutations in the absence of chromatin modifying gene mutations. FL in children have a unique molecular landscape when compared with those in adults. Pediatric-type FL (PTFL) is characterized by MAP2K1, TNFRSF14, and\/or IRF8 mutations, whereas large B-cell lymphoma with IRF4 rearrangement is now recognized as a distinct entity, different from PTFL. Ultimately, a better understanding of FL biology and heterogeneity should help to understand the clinical differences and help guide patient management and treatment decisions.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022009456","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T12:05:40Z","timestamp":1691669140000},"page":"5258-5271","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":29,"title":["The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-9822","authenticated-orcid":false,"given":"Itziar","family":"Salaverria","sequence":"first","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Weigert","sequence":"additional","affiliation":[{"name":"3Laboratory for Experimental Leukemia and Lymphoma Research, Ludwig-Maximilians-University Hospital, Munich, Germany"},{"name":"4Department of Medicine III, Ludwig-Maximilians-University Hospital, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5365","authenticated-orcid":false,"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[{"name":"5Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen, University Hospital T\u00fcbingen, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"6Cluster of Excellence iFIT \u201cImage-guided and functionally Instructed Tumor therapies,\u201d Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"2023092213345528200_bib1","first-page":"266","volume-title":"WHO Classification of Tumours of Haematopoetic and Lymphoid Tissues","author":"Jaffe","year":"2017"},{"issue":"1","key":"2023092213345528200_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"4720","key":"2023092213345528200_bib3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"4","key":"2023092213345528200_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcp\/103.4.472","article-title":"Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma","volume":"103","author":"Horsman","year":"1995","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"2023092213345528200_bib5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"2023092213345528200_bib6","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-03-3604","article-title":"Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides","volume":"64","author":"Roulland","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"2023092213345528200_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404035","article-title":"Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals","volume":"20","author":"Roulland","year":"2006","journal-title":"Leukemia"},{"issue":"7","key":"2023092213345528200_bib8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.20082842","article-title":"Agricultural pesticide exposure and the molecular connection to lymphomagenesis","volume":"206","author":"Agopian","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"13","key":"2023092213345528200_bib9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t(14;18) translocation: a predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"2023092213345528200_bib10","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3109\/10428194.2014.999324","article-title":"Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood","volume":"56","author":"Hirt","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2023092213345528200_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2023092213345528200_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"2023092213345528200_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2023092213345528200_bib14","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"issue":"16","key":"2023092213345528200_bib15","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2023092213345528200_bib16","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.3324\/haematol.2019.226142","article-title":"Clonally related duodenal-type follicular lymphoma and in situ follicular neoplasia","volume":"104","author":"Nann","year":"2019","journal-title":"Haematologica"},{"issue":"2","key":"2023092213345528200_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"7360","key":"2023092213345528200_bib18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"10","key":"2023092213345528200_bib19","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2023092213345528200_bib20","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-23-0111","article-title":"Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors","volume":"13","author":"Schroers-Martin","year":"2023","journal-title":"Cancer Discov"},{"issue":"25","key":"2023092213345528200_bib21","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2018-03-837039","article-title":"CREBBP gene mutations are frequently detected in in situ follicular neoplasia","volume":"132","author":"Schmidt","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2023092213345528200_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","article-title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","volume":"129","author":"Krysiak","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2023092213345528200_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"issue":"5","key":"2023092213345528200_bib24","doi-asserted-by":"crossref","first-page":"107522","DOI":"10.1016\/j.celrep.2020.107522","article-title":"Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma","volume":"31","author":"Bararia","year":"2020","journal-title":"Cell Rep"},{"issue":"5","key":"2023092213345528200_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"2023092213345528200_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"issue":"396","key":"2023092213345528200_bib27","doi-asserted-by":"crossref","first-page":"eaak9969","DOI":"10.1126\/scitranslmed.aak9969","article-title":"Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma","volume":"9","author":"Oricchio","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"2023092213345528200_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"43","key":"2023092213345528200_bib29","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2023092213345528200_bib30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2023092213345528200_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"22","key":"2023092213345528200_bib32","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"18","key":"2023092213345528200_bib33","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1182\/bloodadvances.2022008355","article-title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III\/IV","volume":"6","author":"Los-de Vries","year":"2022","journal-title":"Blood Adv"},{"key":"2023092213345528200_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"issue":"3","key":"2023092213345528200_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"2023092213345528200_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"2023092213345528200_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Zamo","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"2023092213345528200_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"issue":"11","key":"2023092213345528200_bib39","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e31822bd8a8","article-title":"Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups","volume":"35","author":"Ozsan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2023092213345528200_bib40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2023092213345528200_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/PAS.0b013e31817d7470","article-title":"Follicular lymphoma of the thyroid gland","volume":"33","author":"Bacon","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2023092213345528200_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","article-title":"Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia","volume":"468","author":"Quintanilla-Martinez","year":"2016","journal-title":"Virchows Arch"},{"issue":"5","key":"2023092213345528200_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00428-023-03493-x","article-title":"Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"482","author":"Lee","year":"2023","journal-title":"Virchows Arch"},{"key":"2023092213345528200_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","article-title":"Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients","volume":"131","author":"Berg","year":"2023","journal-title":"Hum Pathol"},{"issue":"1","key":"2023092213345528200_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","article-title":"Follicular lymphoma and marginal zone lymphoma: how many diseases?","volume":"482","author":"Laurent","year":"2023","journal-title":"Virchows Arch"},{"issue":"4","key":"2023092213345528200_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"issue":"20","key":"2023092213345528200_bib47","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","article-title":"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype","volume":"118","author":"Leich","year":"2011","journal-title":"Blood"},{"issue":"23","key":"2023092213345528200_bib48","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1182\/bloodadvances.2021005081","article-title":"Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage","volume":"5","author":"Leich","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"2023092213345528200_bib49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A\u00a0distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2023092213345528200_bib50","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.humpath.2013.02.004","article-title":"The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-\"negative\" grade 1\/2 follicular lymphomas","volume":"44","author":"Adam","year":"2013","journal-title":"Hum Pathol"},{"issue":"21","key":"2023092213345528200_bib51","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1182\/bloodadvances.2021005284","article-title":"Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network","volume":"6","author":"Crouch","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"2023092213345528200_bib52","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/s41375-022-01641-x","article-title":"PARP14 is a novel target in STAT6 mutant follicular lymphoma","volume":"36","author":"Mentz","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"2023092213345528200_bib53","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2023092213345528200_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/2159-8290.CD-16-1417","article-title":"The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Cancer Discov"},{"issue":"12","key":"2023092213345528200_bib55","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis","volume":"24","author":"Pangault","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"2023092213345528200_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"issue":"11","key":"2023092213345528200_bib57","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1073\/pnas.90.11.5262","article-title":"Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas","volume":"90","author":"Baron","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023092213345528200_bib58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br J Haematol"},{"issue":"11","key":"2023092213345528200_bib59","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/sj.leu.2402707","article-title":"Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics","volume":"16","author":"Jardin","year":"2002","journal-title":"Leukemia"},{"issue":"22","key":"2023092213345528200_bib60","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1182\/blood-2012-10-464958","article-title":"BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements","volume":"121","author":"Lu","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2023092213345528200_bib61","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V101.3.1149","article-title":"Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive","volume":"101","author":"Bosga-Bouwer","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2023092213345528200_bib62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.humpath.2005.12.005","article-title":"Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?","volume":"37","author":"Bosga-Bouwer","year":"2006","journal-title":"Hum Pathol"},{"issue":"2","key":"2023092213345528200_bib63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"Am J Pathol"},{"issue":"7","key":"2023092213345528200_bib64","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2023092213345528200_bib65","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","article-title":"Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances","volume":"19","author":"Guo","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"2023092213345528200_bib66","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"2023092213345528200_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3324\/haematol.12754","article-title":"Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas","volume":"93","author":"Piccaluga","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"2023092213345528200_bib68","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2023092213345528200_bib69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-022-03421-5","article-title":"Recent advances in cutaneous lymphoma-implications for current and future classifications","volume":"482","author":"Goodlad","year":"2023","journal-title":"Virchows Arch"},{"issue":"3","key":"2023092213345528200_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0000000000002003","article-title":"Follicle center lymphoma (FCL) of the lower female genital tract (LFGT): a novel variant of primary cutaneous follicle center lymphoma (PCFCL)","volume":"47","author":"Saksena","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2023092213345528200_bib71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/his.14378","article-title":"Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma","volume":"79","author":"Hamamoto","year":"2021","journal-title":"Histopathology"},{"issue":"1","key":"2023092213345528200_bib72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation","volume":"229","author":"Cai","year":"2009","journal-title":"Immunol Rev"},{"issue":"4","key":"2023092213345528200_bib73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1309\/AJCPPHKGYYGGL39C","article-title":"High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma\/chronic lymphocytic leukemia","volume":"132","author":"M'Hidi","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2023092213345528200_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","article-title":"Primary follicular lymphoma of the testis in children and adolescents","volume":"34","author":"Lones","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"12","key":"2023092213345528200_bib75","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2023092213345528200_bib76","first-page":"e22023","article-title":"Conjunctival pediatric-type follicular lymphoma in a young male: a case report and literature review","volume":"14","author":"Alnaim","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"2023092213345528200_bib77","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/IOP.0000000000001556","article-title":"Conjunctival pediatric-type follicular lymphoma","volume":"36","author":"Okudolo","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"2023092213345528200_bib78","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2023092213345528200_bib79","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"issue":"16","key":"2023092213345528200_bib80","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","article-title":"A\u00a0unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile","volume":"6","author":"Salmeron-Villalobos","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"2023092213345528200_bib81","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000001932","article-title":"Pediatric-type indolent B-cell lymphomas with overlapping clinical, pathologic, and genetic features","volume":"46","author":"Lim","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2023092213345528200_bib82","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"issue":"10","key":"2023092213345528200_bib83","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A\u00a0study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"2023092213345528200_bib84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2023092213345528200_bib85","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.it.2008.07.006","article-title":"Interferon regulatory factor 4 and 8 in B-cell development","volume":"29","author":"Lu","year":"2008","journal-title":"Trends Immunol"},{"key":"2023092213345528200_bib86","first-page":"280","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Pittaluga","year":"2017"},{"issue":"7","key":"2023092213345528200_bib87","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","article-title":"Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements","volume":"6","author":"Frauenfeld","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"2023092213345528200_bib88","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00428-023-03516-7","article-title":"Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer's ring in adults","volume":"482","author":"Streich","year":"2023","journal-title":"Virchows Arch"},{"issue":"1","key":"2023092213345528200_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"8","key":"2023092213345528200_bib90","doi-asserted-by":"crossref","first-page":"e27770","DOI":"10.1002\/pbc.27770","article-title":"IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials","volume":"66","author":"Chisholm","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2023092213345528200_bib91","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2023092213345528200_bib92","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"issue":"3","key":"2023092213345528200_bib93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"2023092213345528200_bib94","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lympohomas. A report of the 2022 EA4HP\/SH lymphoma workshop","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"issue":"2","key":"2023092213345528200_bib95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00043426-200402000-00007","article-title":"Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy","volume":"26","author":"Heller","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"9","key":"2023092213345528200_bib96","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jcp.55.9.684","article-title":"Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics","volume":"55","author":"Pileri","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"issue":"7","key":"2023092213345528200_bib97","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"2023092213345528200_bib98","first-page":"225","article-title":"Follicular large cell lymphoma localized to the testis in children","volume":"168","author":"Pakzad","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"9","key":"2023092213345528200_bib99","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.3324\/haematol.2018.211631","article-title":"A\u00a0high definition picture of key genes and pathways mutated in pediatric follicular lymphoma","volume":"104","author":"Lovisa","year":"2019","journal-title":"Haematologica"},{"issue":"suppl 4","key":"2023092213345528200_bib100","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"2023092213345528200_bib101","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dreyling","year":"2021","journal-title":"Ann Oncol"},{"issue":"4","key":"2023092213345528200_bib102","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/leu.2015.330","article-title":"Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus","volume":"30","author":"Leich","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"2023092213345528200_bib103","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"2023092213345528200_bib104","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1097\/HS9.0000000000000767","article-title":"Molecular cytogenetic profiling reveals similarities and differences between localized nodal and systemic follicular lymphomas","volume":"6","author":"Horn","year":"2022","journal-title":"Hemasphere"},{"issue":"8","key":"2023092213345528200_bib105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.2019000847","article-title":"The immune landscape and response to immune checkpoint blockade therapy in lymphoma","volume":"135","author":"Kline","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2023092213345528200_bib106","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/asheducation-2018.1.194","article-title":"Novel immunotherapy approaches to follicular lymphoma","volume":"2018","author":"Flowers","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"2023092213345528200_bib107","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","article-title":"Distinction of lymphoid and myeloid clonal hematopoiesis","volume":"27","author":"Niroula","year":"2021","journal-title":"Nat Med"},{"issue":"21","key":"2023092213345528200_bib108","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5258\/2079843\/blooda_adv-2022-009456-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5258\/2079843\/blooda_adv-2022-009456-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T09:35:57Z","timestamp":1695375357000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/18\/5258\/497402\/The-clinical-and-molecular-taxonomy-of-t-14-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":108,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009456","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}